Related Experiment Video
Updated: Sep 11, 2025

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Early detection of right atrial dysfunction in patients with hypertrophic cardiomyopathy using cardiac magnetic
Wanzhen Li1,2,3, Yiyuan Gao1, Jingjing Shi1
1Department of Radiology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), The First School of Clinical Medicine of Zhejiang Chinese Medical University, Hangzhou, China.
Insights
Hypertrophic cardiomyopathy (HCM) patients show impaired right atrial (RA) function, even without RA enlargement. Cardiac magnetic resonance-feature tracking (CMR-FT) can detect this early RA dysfunction.
Area of Science:
- Cardiology
- Medical Imaging
- Biomedical Engineering
Background:
- Right heart evaluation is crucial in hypertrophic cardiomyopathy (HCM).
- Cardiac magnetic resonance-feature tracking (CMR-FT) quantifies cardiac function and myocardial deformation.
- Early detection of right atrial (RA) dysfunction in HCM is important.
Purpose of the Study:
- To evaluate if early RA dysfunction in HCM patients, with or without RA enlargement (RAE), can be detected using CMR-FT.
- To assess RA strain and strain rate parameters in HCM patients compared to healthy controls.
Main Methods:
- Retrospective analysis of 143 HCM patients (25 RAE, 118 non-RAE) and 70 controls.
- Utilized CMR-FT to obtain RA reservoir strain (εs), conduit strain (εe), booster strain (εa), and strain rates (SRs, SRe, SRa).
- Statistical analysis included Chi-square, ANOVA, linear regression, ICCs, and Bland-Altman plots.
Main Results:
- HCM patients (both RAE and non-RAE groups) exhibited significantly lower RA εs, εe, εa, SRs, SRe, SRa, and RA emptying fraction (RAEF) booster values compared to controls.
- HCM RAE group showed greater indexed RA maximum, pre-atrial contractile, and minimum volumes than controls and non-RAE groups.
- RA strain parameters significantly correlated with right ventricular ejection fraction (RVEF).
Conclusions:
- Patients with HCM have impaired RA reservoir, conduit, and booster pump function, irrespective of RA volumes.
- CMR-FT-derived RA strain and strain rate are more sensitive indicators of early RA dysfunction in HCM than traditional RAEF metrics.
Background:
The importance of right heart evaluation in hypertrophic cardiomyopathy (HCM) is being increasingly acknowledged in both clinical practice and research. Cardiac magnetic resonance-feature tracking (CMR-FT) has emerged as a valuable approach for quantifying cardiac function and myocardial deformation. This study aimed to evaluate whether early right atrial (RA) dysfunction in patients with HCM, with or without RA enlargement (RAE), could be detected with CMR-FT.
Methods:
A total of 143 patients with HCM, divided into an RAE group (n=25) and a non-RAE group (n=118), along with 70 age- and gender-matched healthy controls were retrospectively included from June 2023 to July 2024 at three tertiary hospitals. RA reservoir strain (εs), conduit strain (εe), booster strain (εa), peak positive strain rate (SRs), peak early negative strain rate (SRe), and peak late negative strain rate (SRa) were obtained using CMR-FT. The Chi-square test, one-way analysis of variance (ANOVA) with post-hoc analysis, linear regression analysis, intraclass correlation coefficients (ICCs), and Bland-Altman plots were applied for statistical analysis.
Results:
The HCM RAE group had significantly greater indexed RA maximum, pre-atrial contractile, and minimum volumes than did both the healthy control group and the HCM non-RAE group (all P values <0.05); there were no significant differences between the healthy control group and the HCM non-RAE group. Both the RAE and non-RAE groups exhibited significantly lower RA εs (31.77%±10.08% vs. 31.62%±13.04% vs. 48.34%±12.45%), εe (15.36%±7.12% vs. 16.66%±8.71% vs. 28.83%±11.04%), εa (16.40%±7.50% vs. 14.97%±7.04% vs. 19.51%±5.81%), SRs (1.69±0.81 vs. 1.78±0.81 vs. 2.10±0.70 s-1), SRe (-1.29±0.61 vs. -1.32±0.70 vs. -2.25±1.04 s-1), SRa (-1.68±0.80 vs. -1.66±0.84 vs. -2.14±0.70 s-1), and RA emptying fraction (RAEF) booster values than control group (all P values <0.05), while there was no difference in RAEF total or RAEF passive between the three groups. Simple linear regression analysis revealed significant correlations between RA strain parameters and right ventricular ejection fraction (RVEF) (εs and RVEF: r=0.56, P<0.001; εe and RVEF: r=0.48, P<0.001; εa and RVEF: r=0.42, P<0.001). The reproducibility indices of RA deformation parameters were reasonably good, with all ICCs >0.75 and narrow limits of agreement in the Bland-Altman plots.
Conclusions:
Patients with HCM exhibit impaired RA reservoir, conduit, and booster pump function even in the presence of normal RA volumes. CMR-FT-derived RA strain and strain rate may serve as more sensitive indicators than traditional RAEF metrics for identifying early RA dysfunction in patients with HCM.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Stenosis II: Clinical features and Diagnostic Tests
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Cardiomyopathy IV: Restrictive Cardiomyopathy
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

